Cryo-Cell International, Inc. (CCEL)
USD 5.57
(2.58%)
USD 5.57
(2.58%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -9.52 Million USD | -443.57% |
| 2022 | 2.77 Million USD | 33.02% |
| 2021 | 2.08 Million USD | -42.52% |
| 2020 | 3.62 Million USD | 58.23% |
| 2019 | 2.29 Million USD | 367.98% |
| 2018 | -854.82 Thousand USD | -136.92% |
| 2017 | 2.31 Million USD | 275.28% |
| 2016 | -1.32 Million USD | -116.29% |
| 2015 | 8.1 Million USD | 1364.24% |
| 2014 | 553.62 Thousand USD | 1917.87% |
| 2013 | 27.43 Thousand USD | 100.43% |
| 2012 | -6.3 Million USD | -201.04% |
| 2011 | -2.09 Million USD | -161.44% |
| 2010 | 3.41 Million USD | 139.39% |
| 2009 | 1.42 Million USD | 287.36% |
| 2008 | -760.41 Thousand USD | 84.81% |
| 2007 | -5 Million USD | -78.04% |
| 2006 | -2.81 Million USD | -372.05% |
| 2005 | 1.03 Million USD | -63.62% |
| 2004 | 2.84 Million USD | 137.76% |
| 2003 | -7.52 Million USD | -41.19% |
| 2002 | -5.32 Million USD | -692.18% |
| 2001 | 899.63 Thousand USD | 160.35% |
| 2000 | -1.49 Million USD | -148.45% |
| 1999 | -600 Thousand USD | 73.91% |
| 1998 | -2.3 Million USD | -43.75% |
| 1997 | -1.6 Million USD | -366.67% |
| 1996 | 600 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 556.24 Thousand USD | 104.97% |
| 2024 Q2 | 655.79 Thousand USD | 17.9% |
| 2024 Q3 | 1.05 Million USD | 60.37% |
| 2023 Q2 | 220.97 Thousand USD | -71.18% |
| 2023 Q1 | 766.81 Thousand USD | -8.48% |
| 2023 Q4 | -11.19 Million USD | -1744.23% |
| 2023 FY | -9.52 Million USD | -443.57% |
| 2023 Q3 | 680.56 Thousand USD | 207.98% |
| 2022 Q3 | 466.82 Thousand USD | -26.45% |
| 2022 FY | 2.77 Million USD | 33.02% |
| 2022 Q1 | 832.04 Thousand USD | 230.58% |
| 2022 Q2 | 634.71 Thousand USD | -23.72% |
| 2022 Q4 | 837.82 Thousand USD | 79.47% |
| 2021 Q1 | 693.59 Thousand USD | -42.19% |
| 2021 Q4 | -637.19 Thousand USD | -174.4% |
| 2021 Q2 | 1.17 Million USD | 68.78% |
| 2021 FY | 2.08 Million USD | -42.52% |
| 2021 Q3 | 856.49 Thousand USD | -26.83% |
| 2020 Q4 | 1.19 Million USD | 52.95% |
| 2020 Q2 | 953.33 Thousand USD | 38.78% |
| 2020 Q1 | 686.96 Thousand USD | -18.7% |
| 2020 FY | 3.62 Million USD | 58.23% |
| 2020 Q3 | 784.46 Thousand USD | -17.71% |
| 2019 Q4 | 844.96 Thousand USD | -24.3% |
| 2019 Q2 | 53.67 Thousand USD | -80.54% |
| 2019 Q3 | 1.11 Million USD | 1979.74% |
| 2019 Q1 | 275.87 Thousand USD | -69.03% |
| 2019 FY | 2.29 Million USD | 367.98% |
| 2018 Q3 | 244.98 Thousand USD | -54.59% |
| 2018 FY | -854.82 Thousand USD | -136.92% |
| 2018 Q4 | 890.75 Thousand USD | 263.6% |
| 2018 Q2 | 539.5 Thousand USD | 121.32% |
| 2018 Q1 | -2.53 Million USD | -472.5% |
| 2017 FY | 2.31 Million USD | 275.28% |
| 2017 Q2 | 496.94 Thousand USD | 2.06% |
| 2017 Q3 | 652.01 Thousand USD | 31.21% |
| 2017 Q4 | 679.21 Thousand USD | 4.17% |
| 2017 Q1 | 486.92 Thousand USD | -39.84% |
| 2016 Q1 | -122.93 Thousand USD | 43.98% |
| 2016 Q3 | -2.64 Million USD | -515.04% |
| 2016 Q2 | 637.13 Thousand USD | 618.26% |
| 2016 Q4 | 809.36 Thousand USD | 130.61% |
| 2016 FY | -1.32 Million USD | -116.29% |
| 2015 Q1 | 286.17 Thousand USD | 196.73% |
| 2015 Q2 | 210.03 Thousand USD | -26.61% |
| 2015 Q3 | 7.82 Million USD | 3627.8% |
| 2015 FY | 8.1 Million USD | 1364.24% |
| 2015 Q4 | -219.43 Thousand USD | -102.8% |
| 2014 FY | 553.62 Thousand USD | 1917.87% |
| 2014 Q3 | 236.57 Thousand USD | 9.64% |
| 2014 Q4 | -295.83 Thousand USD | -225.05% |
| 2014 Q2 | 215.77 Thousand USD | -45.66% |
| 2014 Q1 | 397.11 Thousand USD | 337.3% |
| 2013 FY | 27.43 Thousand USD | 100.43% |
| 2013 Q1 | 244 Thousand USD | 128.56% |
| 2013 Q2 | -243.65 Thousand USD | -199.86% |
| 2013 Q3 | 194.43 Thousand USD | 179.8% |
| 2013 Q4 | -167.34 Thousand USD | -186.07% |
| 2012 Q1 | -1.68 Million USD | -1256.96% |
| 2012 FY | -6.3 Million USD | -201.04% |
| 2012 Q4 | -854.38 Thousand USD | -56.17% |
| 2012 Q3 | -547.09 Thousand USD | 83.04% |
| 2012 Q2 | -3.22 Million USD | -91.72% |
| 2011 Q1 | 233.41 Thousand USD | -40.77% |
| 2011 Q3 | -2.38 Million USD | -1442.74% |
| 2011 FY | -2.09 Million USD | -161.44% |
| 2011 Q4 | -123.95 Thousand USD | 94.8% |
| 2011 Q2 | 177.42 Thousand USD | -23.99% |
| 2010 Q2 | 387.74 Thousand USD | 4.62% |
| 2010 Q3 | 2.36 Million USD | 509.56% |
| 2010 Q1 | 370.6 Thousand USD | 233.48% |
| 2010 Q4 | 394.05 Thousand USD | -83.33% |
| 2010 FY | 3.41 Million USD | 139.39% |
| 2009 Q3 | 432.09 Thousand USD | -43.82% |
| 2009 Q1 | 553.97 Thousand USD | 1637.2% |
| 2009 Q2 | 769.08 Thousand USD | 38.83% |
| 2009 Q4 | -277.65 Thousand USD | -164.26% |
| 2009 FY | 1.42 Million USD | 287.36% |
| 2008 Q4 | 31.88 Thousand USD | 116.85% |
| 2008 Q1 | -247.25 Thousand USD | 85.17% |
| 2008 Q2 | -355.74 Thousand USD | -43.88% |
| 2008 Q3 | -189.3 Thousand USD | 46.79% |
| 2008 FY | -760.41 Thousand USD | 84.81% |
| 2007 Q4 | -1.66 Million USD | -45.25% |
| 2007 FY | -5 Million USD | -78.04% |
| 2007 Q1 | -786.66 Thousand USD | 15.16% |
| 2007 Q2 | -1.4 Million USD | -78.41% |
| 2007 Q3 | -1.14 Million USD | 18.21% |
| 2006 Q3 | -1.07 Million USD | -25.51% |
| 2006 Q4 | -927.21 Thousand USD | 14.11% |
| 2006 Q2 | -860.13 Thousand USD | -1649.01% |
| 2006 Q1 | 55.52 Thousand USD | -60.84% |
| 2006 FY | -2.81 Million USD | -372.05% |
| 2005 Q1 | 178.63 Thousand USD | 12.33% |
| 2005 Q2 | 115.57 Thousand USD | -35.3% |
| 2005 Q4 | 141.81 Thousand USD | -76.26% |
| 2005 Q3 | 597.39 Thousand USD | 416.91% |
| 2005 FY | 1.03 Million USD | -63.62% |
| 2004 Q3 | 1.85 Million USD | 205.49% |
| 2004 Q1 | 214.28 Thousand USD | 104.87% |
| 2004 Q4 | 159.02 Thousand USD | -91.44% |
| 2004 Q2 | 608.41 Thousand USD | 183.92% |
| 2004 FY | 2.84 Million USD | 137.76% |
| 2003 Q3 | -889.48 Thousand USD | 30.19% |
| 2003 FY | -7.52 Million USD | -41.19% |
| 2003 Q1 | -958.65 Thousand USD | 73.07% |
| 2003 Q4 | -4.39 Million USD | -394.6% |
| 2003 Q2 | -1.27 Million USD | -32.9% |
| 2002 Q3 | -1.54 Million USD | -464.58% |
| 2002 Q1 | 46.64 Thousand USD | -82.93% |
| 2002 Q2 | -273.05 Thousand USD | -685.43% |
| 2002 FY | -5.32 Million USD | -692.18% |
| 2002 Q4 | -3.55 Million USD | -130.89% |
| 2001 Q4 | 273.25 Thousand USD | 0.41% |
| 2001 Q3 | 272.14 Thousand USD | -57.61% |
| 2001 Q2 | 642.01 Thousand USD | 323.09% |
| 2001 Q1 | -287.78 Thousand USD | 47.89% |
| 2001 FY | 899.63 Thousand USD | 160.35% |
| 2000 FY | -1.49 Million USD | -148.45% |
| 2000 Q4 | -552.28 Thousand USD | -112.01% |
| 2000 Q3 | -260.49 Thousand USD | -7.72% |
| 2000 Q2 | -241.82 Thousand USD | 31.37% |
| 2000 Q1 | -352.35 Thousand USD | -276.18% |
| 1999 Q2 | -100 Thousand USD | 75.0% |
| 1999 Q1 | -400 Thousand USD | 73.33% |
| 1999 Q4 | 200 Thousand USD | 166.67% |
| 1999 Q3 | -300 Thousand USD | -200.0% |
| 1999 FY | -600 Thousand USD | 73.91% |
| 1998 Q2 | -500 Thousand USD | 0.0% |
| 1998 FY | -2.3 Million USD | -43.75% |
| 1998 Q4 | -1.5 Million USD | -850.0% |
| 1998 Q3 | 200 Thousand USD | 140.0% |
| 1998 Q1 | -500 Thousand USD | 37.5% |
| 1997 Q4 | -800 Thousand USD | -100.0% |
| 1997 Q1 | -100 Thousand USD | 75.0% |
| 1997 Q2 | -300 Thousand USD | -200.0% |
| 1997 FY | -1.6 Million USD | -366.67% |
| 1997 Q3 | -400 Thousand USD | -33.33% |
| 1996 Q2 | 900 Thousand USD | 200.0% |
| 1996 Q3 | -200 Thousand USD | -122.22% |
| 1996 Q4 | -400 Thousand USD | -100.0% |
| 1996 FY | 600 Thousand USD | 0.0% |
| 1996 Q1 | 300 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 56.055% |
| Addus HomeCare Corporation | 62.51 Million USD | 115.231% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | -112.585% |
| Amedisys, Inc. | -9.74 Million USD | 2.312% |
| American Oncology Network, Inc. | -5.54 Million USD | -71.809% |
| Astrana Health, Inc. | 60.71 Million USD | 115.682% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 92.922% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 387.143% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 113.11% |
| COMPASS Pathways plc | -118.46 Million USD | 91.962% |
| DocGo Inc. | 6.85 Million USD | 238.831% |
| The Ensign Group, Inc. | 209.39 Million USD | 104.547% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 124.805% |
| InnovAge Holding Corp. | -21.33 Million USD | 55.377% |
| Assure Holdings Corp. | -26.07 Million USD | 63.488% |
| The Joint Corp. | -9.75 Million USD | 2.364% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 94.888% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 38.975% |
| ModivCare Inc. | -204.46 Million USD | 95.343% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 7413.503% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | 27.946% |
| Option Care Health, Inc. | 267.09 Million USD | 103.565% |
| P3 Health Partners Inc. | -57.77 Million USD | 83.519% |
| P3 Health Partners Inc. | -57.77 Million USD | 83.519% |
| The Pennant Group, Inc. | 13.37 Million USD | 171.169% |
| Surgery Partners, Inc. | -11.9 Million USD | 19.986% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -224.049% |
| Talkspace, Inc. | -19.18 Million USD | 50.361% |
| Talkspace, Inc. | -19.18 Million USD | 50.361% |
| The Oncology Institute, Inc. | -83.06 Million USD | 88.538% |
| The Oncology Institute, Inc. | -83.06 Million USD | 88.538% |